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Abstract
Background: Traditional Chinese Medicine (TCM) is characterized by the wide use of herbal formulae, which are
capable of systematically treating diseases determined by interactions among various herbs. However, the
combination rule of TCM herbal formulae remains a mystery due to the lack of appropriate methods.
Methods: From a network perspective, we established a method called Distance-based Mutual Information Model
(DMIM) to identify useful relationships among herbs in numerous herbal formulae. DMIM combines mutual
information entropy and “between-herb-distance” to score herb interactions and construct herb network. To
evaluate the efficacy of the DMIM-extracted herb network, we conducted in vitro assays to measure the activities of
strongly connected herbs and herb pairs. Moreover, using the networked Liu-wei-di-huang (LWDH) formula as an
example, we proposed a novel concept of “co-module” across herb-biomolecule-disease multilayer networks to
explore the potential combination mechanism of herbal formulae.
Results: DMIM, when used for retrieving herb pairs, achieves a good balance among the herb’s frequency,
independence, and distance in herbal formulae. A herb network constructed by DMIM from 3865 Collaterals-related
herbal formulae can not only nicely recover traditionally-defined herb pairs and formulae, but also generate novel
anti-angiogenic herb ingredients (e.g. Vitexicarpin with IC50=3.2 μM, and Timosaponin A-III with IC50=3.4 μM) as
well as herb pairs with synergistic or antagonistic effects. Based on gene and phenotype information associated
with both LWDH herbs and LWDH-treated diseases, we found that LWDH-treated diseases show high phenotype
similarity and identified certain “co-modules” enriched in cancer pathways and neuro-endocrine-immune pathways,
which may be responsible for the action of treating different diseases by the same LWDH formula.
Conclusions: DMIM is a powerful method to identify the combination rule of herbal formulae and lead to new
discoveries. We also provide the first evidence that the co-module across multilayer networks may underlie the
combination mechanism of herbal formulae and demonstrate the potential of network biology approaches in the
studies of TCM.
Background
Traditional Chinese Medicine (TCM) is an important
part of the current medical system. It aims to restore
the whole-body balance in patients by using herbal for-
mula (Fang-Ji in Mandarin), which is usually composed
of two or more medicinal herbs and has the capacity of
systematically treating disease [1]. Naturally occurring
herbs and herbal ingredients organized into certain for-
mula have been shown to have potential interaction
effects. These include mutual enhancement, mutual
assistance, mutual restraint and mutual antagonism
[2,3]. For example, synergistic interactions occur when
the efficacy of combinations of herbs (or ingredients) is
greater than the summed responses of each individual
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the synergistic, additive and antagonistic effects exerted
by different combinations of six herbal extracts on the
viability of prostate cancer cell lines. Wang reported
that a Realgar-Indigo naturalis formula is beneficial for
the treatment of promyelocytic leukemia; the synergistic
e f f e c t se x e r t e db ys e v e r a lc o m p o n e n t so ft h i sf o r m u l a
are well documented [5]. Ung et al.[ 6 ]c o n d u c t e da n
analysis of 394 TCM herb pairs and 2470 non-TCM
herb pairs using artificial intelligence methods and con-
sidering four classes of herbal properties as features
including character, taste, meridian, and toxicity level.
Their study revealed that herb pairs in TCM contain
features distinguishable from those of non-TCM herb
pairs. Schmidt et al.[ 7 ]b e l i e v e dt h a tm i x t u r e so fi n t e r -
acting compounds produced by plants may become a
valuable asset and an important resource for drug dis-
covery, especially for the development of combinational
therapeutics.
However, there is still a lack of appropriate methods
to learn how and why many herbs are grouped in cer-
tain formulae, and the combination rule embedding
numerous herbal formulae remain unknown. Tradition-
ally herbs have taken different roles in a typical herbal
formula; they are usually expressed in the organization
order as Master, Adviser, Soldier and Guide (MASG),
each of which is given certain natural properties includ-
ing Cold, Cool, Neutral, Warm or Hot. Understanding
the combination rule of herbal formulae will not only
benefit the modernization of TCM but may also be
helpful for the way drugs are studied. A good example
of the potential of TCM involves angiogenesis. TCM is
known to be effective for the treatment of angiogenesis
which is the main type of pathological vascular growth
associated with various diseases such as cancer and
rheumatoid arthritis [8,9]. We know that more than
60% of the current cancer chemotherapeutic agents are
natural products or small molecules based on natural
product leads [10,11]. Many pro-angiogenic and anti-
angiogenic plant components are potentially useful for
curing angiogenic disorders and are well tolerated [9].
Especially, herbs originally used for treating “Collaterals
(Luo in Mandarin) diseases” in TCM have been found
to be active on angiogenic disorders [12]. As a conse-
quence, combining traditional herbal formulae with
existing biological knowledge might allow researchers to
rapidly identify combination treatments for angiogenic
disorders.
Recently, a remarkable development has been the use
of systems biology, especially network biology, in drug
study. This methodology has revealed the systematic
mechanisms of complex disease and has highlighted the
paradigm shift from “one drug, one target” to “multi-
component therapeutics, biological networks” [13,14].
Even though the scientific community has high expecta-
tions for systems pharmacology, this field is still in its
infancy because of a poor understanding of cell beha-
viours and drug-protein interactions. TCM formula is
considered to be an empirical system of multicompo-
nent therapeutics which potentially meets the demands
of treating a number of complex diseases in an inte-
grated manner [3,14,15]. So, in order to find a relation-
ship between groups of drugs and complex diseases, it is
important to introduce a powerful approach to bridge
the tradition and the modern, and pursue ap r i o r i
knowledge about the combination rules embedded in
TCM. In this work, we developed a Distance-based
Mutual Information Model (DMIM) to extract the herb
relationships from plentiful herbal formulae. This
method was then used to construct the “herb network”
from 3865 Collaterals-related herbal formulae, following
by in vitro experiments designed to evaluate the angio-
genic effects and synergistic properties of strongly
connected herbs and herb pairs. A new concept of
“co-module” was further proposed and network biology
analyses were conducted to explore the potential combi-
nation mechanism of the networked herbal formulae.
Methods
Data sources of herbal formulae
Candidate herbal formulae selection
TCM values the “Collaterals” theory and therapy. Using
“Collaterals (Luo)” as the keyword, we searched the
SIRC-TCM Herbal Formula database (http://www.
tcm120.com/1w2k/tcm_recipe.asp) which contains 0.14
million herbal formulae. Then we collected 3865 herbal
formulae with formula names and functions, or herb’s
meridian tropism (Gui-jing in Mandarin), or targeted
syndromes and diseases containing the keyword. We
standardized the herbal formulae by substituting all
the polysemes, synonyms and acronyms of the herbs in
the dataset using the standardized Herb Name list. The
standardized Herb Name list consists of 737 herbs. The
3865 Collaterals-related herbal formulae, as examples,
will be subject to the following DMIM analysis.
Traditionally-defined herb pairs
The herb pair is the basic unit of a herbal formula. To
evaluate the reliability and utility of the DMIM-
extracted herb network, 600 traditionally-defined herb
pairs recorded in [16] and 301 herb pairs from [17]
were collected. This resulted in 775 non-redundant tra-
ditionally-defined herb pairs made up of 737 separate
herbs in the Collaterals-related herbal formulae.
Establishment of DMIM Scoring System
Numerical representation for herbal formulae
In the DMIM, we turn the normalized formula data into
a numeral matrix to indicate the relative position of the
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herbs and m formulae, we assign serial numbers to all
the herbs from 1 to n. As illustrated in Table 1, we use
a m×n matrix A =( aij)m*n to indicate the formula where
the ith row vector denotes the components of the ith
formula, and aij is the number of the position of the jth
herb in ith formula ( aij =0 means herb j is absent in
formula i). To eliminate the impact of the total number
of herbs in one formula, we define the matrix B=(bij)
as
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1 where k denotes the total number of
herbs in a formula.
From this we had matrix B ,w h e r ebij indicates the
relative position of herb j in the formula i. Finally, the
real data set is represented by a 3865×737 matrix. Then,
for given two herbs, x and y, we deduce that the ten-
dency of x and y to form a herb pair is dependent on
two factors: mutual information entropy characteristics
and the average distance between herbs.
Mutual information entropy
To begin with, we calculate the traditional
mutual information entropy [21] for x and y as:
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the indicator function of x and y, showing whether herb
x and y coexist in the formula i.
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1 is the fre-
quency of herb x. It is the same with P(y). A large value
of MI(x, y) indicates a strong correlation between herb x
and herb y.
Between-herb-distance
Considering a later order indicates a less importance in
the organization of Master, Adviser, Soldier or Guide
herbs in a herbal formula, we assume that the further
the distance between two herbs in a formula, the less
likely they are to be relevant to one another. The dis-
tance between herb x and herb y in the ith formula,
called the “between-herb-distance”, is defined as: d(x, y,
i)=| B(x,i)-B(y, i)|. The average distance of herb x and
herb y in the dataset is dxy
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DMIM scoring system
The DMIM combines the mutual information
(MI) entropy characteristics and the average
distance between herbs (d)t of o r mas c o r i n gs y s -
tem, score x y
MI x y
dx y
,
,
, () = ()
()
, which describes the ten-
dency of herb x and herb y to form a herb pair. So
when two herb pairs share the same information
entropy, the one with the smaller average distance
shows a stronger connection. When two herb pairs have
the same average distance, the one with the larger infor-
mation entropy shows a greater interaction.
Evaluation of the DMIM-extracted herb network
In vitro assays for evaluating angiogenic activities of
DMIM-extracted herbs
We selected major herbal ingredients from DMIM
outputs to evaluate angiogenic activities. Two kinds of
endothelial cell proliferation assays, namely with or
without vascular endothelial growth factor (VEGF) sti-
mulation, were used to evaluate respectively the anti-
angiogenic or the pro-angiogenic activity of herbal
ingredients. Only the positive results were reported.
Human Umbilical Vein Endothelial Cells (HUVECs)
from Cascade Biologics (Portland, USA) were cultured
in endothelial cell medium (Sciencell Research Labo-
ratory) together with 10% fetal bovine serum and
endothelial cell growth supplement. This mixture was
sub-cultured using a 1:2 ratio with Trypsin/EDTA
solution provided by the manufacturer. Herbal ingredi-
ents were purchased from the National Institute for the
Control of Pharmaceutical and Biological Products,
China. HUVECs (5×10
3 per well) in a 96-well plate
were starved with 0.1% FBS medium and then treated
with or without VEGF (5-10 ng/ml) along with differ-
ent concentrations of herbal ingredients for 48 hours.
Cell viability was determined by Cell Counting Kit
(CCK-8, Dojindo, Japan) following the measurement of
optical density values using MRX Revelation Absor-
bance Reader.
Herb interaction measurement of DMIM-extracted herb
pairs
We investigated whether combination effects were pro-
duced by DMIM-extracted herb pairs and whether there
Table 1 Examples for the numerical representation of herbal formulae
Formula herb1 herb2 herb3 herb4 herb5 herb6 herb7 herb8 herb9 herb10
Formula 1 0 0.5 0 0.25 0 1 0 0 0.75 0
Formula 2 0.375 0.625 0.875 0.125 0.75 0 1 0.25 0 0.5
Formula 3 0 . 500001000 0
*Assume there are a total of 10 herbs denoted by herb1, herb2…herb10 (j=1, 2…,10), and three herbal formulae containing the following herbs in sequence
(i=1,2,3): Formula 1: herb4, herb2, herb9 and herb6 (k=4); Formula 2: herb4, herb8, herb1, herb10, herb2, herb5, herb3 and herb7 (k=8); and Formula 3: herb1 and
herb6 (k=2). For herb2 in Formula 1, we calculated that a12 =2 and b12=2/4=0.5. The matrix representation for this artificial data set is shown in the table.
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highest single compound model [18] was used as the
reference model for measuring additivity to identify her-
bal interactions such as synergism or antagonism. The
combination effects were determined by selecting the
greatest effect produced by each of the combination’s
individual compounds using similar concentrations as in
the combination. Positive or negative deviations from
this predicted additivity demonstrated synergistic or
antagonistic interactions.
Co-module analysis for the DMIM-extracted herbal
formula
Co-module concept, herbal formula selection and biological
data preparation
To further explore the combination mechanism of
DMIM-extracted herbal formulae, we propose a new
concept of “co-module” based on the assumption that
there may exist certain consistent and common biologi-
cal patterns, which act as “co-modules”, underlying net-
worked herbs and their targeted diseases simultaneously.
We took a famous formula, “Liu-wei-di-huang” (LWDH,
also known as Rehmannia Six, Six Ingredient Rehman-
nia or Rokumi-gan), as an example, since we found that
all six herbs of this formula are connected closely in the
DMIM-extracted herb network including Shan-zhu-yu
(Fructus Corni), Ze-xie (Rhizoma Alismatis), Dan-pi
(Cortex Moutan), Di-huang (Radix Rehmaniae), Fu-ling
(Poria Cocos) and Shan-yao (Rhizoma Dioscoreae).
Then, we collected the biological entities (genes or gene
products) affected by individual herbs (compounds) of
LWDH from PubMed and China National Knowledge
Infrastructure (http://www.cnki.net). This resulted in a
total of 146 manually collected genes or gene products,
called LWDH genes, contributed respectively to the
actions of the LWDH constituent six herbs. 127 LWDH
genes were nodes of the protein-protein interaction
(PPI) network (HPRD, release 7). Next, we collected the
documented diseases for which the LWDH formula may
serve as a potential treatment. This resulted in 16 dis-
eases containing 9 types of cancer (Prostate cancer, Mel-
anoma, Stomach cancer, Breast cancer, Esophageal
cancer, Lung cancer, Hepatocellular carcinoma, Multiple
myeloma and Leukemia), 5 diseases with dysfunction of
the neuro-endocrine-immune-metabolism system (Par-
kinson disease, Asthma, Allergy, Rheumatoid arthritis
and Diabetes), and 2 cardiovascular disorders (Hyperten-
sion and Atherosclerosis) (see literature in Additional
file 1). By mapping these 16 diseases into the OMIM
database, we identified 73 exclusive phenotypes with
OMIM IDs and obtained 224 disease genes called
LWDH-disease genes, 173 of which were networked in
HPRD.
Performing co-module analysis for LWDH and LWDH-
treated diseases
We conducted the co-module analysis from the following
three aspects. (1) We analyzed the enriched KEGG path-
ways for either LWDH genes or LWDH-disease genes
with a false discovery rate less than 0.05 by Fisher Exact
test in DAVID [19]. (2) We evaluated the “closenes-
s”(average shortest path) between LWDH genes and
LWDH-disease genes in the PPI network and used the
permutation test to calculate the statistical significance of
the average shortest path. Here we kept the original 127
LWDH genes and randomly selected other 173 disease
genes from 1273 networked genes in all 3074 non-redun-
dant disease genes stored in the OMIM moridmap.txt
(Feb 22, 2008); this was repeated independently 2000
times. (3) We calculated the average phenotype similarity
score determined by the cosine of vector angle [20] of 73
phenotypes of LWDH-diseases, and evaluated the statisti-
cal significance by comparison with randomly selected 73
OMIM phenotypes for 2000 times.
Statistical analysis
The mutual information statistics were transformed to
equivalent odds ratios using monotonic transform and
then subjected to standard c
2 test. In doing so, we used
c
2 test to test whether the occurrence of the two herbs
in the formulae is correlated with each other by generat-
ing a contingency table. Experimental data from the in
vitro assay were presented as mean±SD (Standard
Deviation) of four independent experiments with six
repeat wells for each experiment. The statistical differ-
ence between treatments was determined by the t test.
Results
DMIM-extracted herb network from Collaterals-related
formulae
DMIM was used for extracting the combination rule of
3865 Collaterals-related formulae. In all 3865 formulae,
we found that eight of the top 10 most frequently occur-
ring herbs (Table 2) are reported to pro-angiogenesis or
anti-angiogenesis activity [9,22]. This provides evidence
that the Collaterals-related formulae may have a possible
relationship with angiogenic disorders. Each of the top
100 DMIM-extracted herb pairs had statistical signifi-
cance (P < 0.05, x
2 test). Table 3 summarized the top 20
DMIM-extracted herb pairs with the highest rankings; six
of these herb pairs are novel when compared with tradi-
tionally-defined herb pairs [16,17]. Interestingly, we found
that Gan-cao (Radix Rhizoma Glycyrrhizae), a com-
monly-used supplementary herb (“Guide” in MASG),
ranked 2nd with a frequency of 38.37% in all 3865 herbal
formulae. However, the position of herb pairs containing
Gan-cao fell to 195 (Table 3), suggesting that the DMIM
Li et al. BMC Bioinformatics 2010, 11(Suppl 11):S6
http://www.biomedcentral.com/1471-2105-11-S11
Page 4 of 12method was able to balance the frequency, independence,
and relative distance in the herbal formulae. Figure 1
shows that we constructed a herb network by using the
interactions of the top 100 herb pairs extracted by
DMIM, in which we found that full or part of six classi-
cal herbal formulae are nicely recovered. The distinct
modular feature is also observed from the DMIM-
extracted herb network.
Measurement of angiogenic activities for DMIM-extracted
modular herbs
As shown in Figure 1, the hub module or the intercon-
nected sub-network in the DMIM-extracted herb net-
work is centered on the most frequently occurring
herbs, Chuan-xiong (Rhizoma Chuanxiong)a n dD a n g -
gui (Radix Angelicae Sinensis). We extended this hub
module to all herb pairs with statistical significance
Table 2 Top 10 herbs in 3865 Collaterals-related formulae
Rank Herbs in Collaterals-related herbal formula Natural Property Frequency Angiogenesis activity [9,22]
Chinese Name English Name
1 Dang-gui Radix Angelicae Sinensis Warm 49.50% Pro-angiogenesis
2 Gan-cao Radix Rhizoma Glycyrrhizae Neutral 38.37% Anti-angiogenesis
3 Chuan-xiong Rhizoma Chuanxiong Warm 32.32% Pro-angiogenesis
4 Chi-shao Radix Paeoniae Rubra Cool 30.79% Pro-angiogenesis
5 Dan-shen Radix et Rhizoma Salviae Miltiorrhizae Cool 29.62% Pro-/Anti-angiogenesis
6 Niu-xi Radix Achyranthis Bidentatae Neutral 26.39% Unknown
7 Huang-qi Radix Astragali Warm 25.85% Pro-angiogenesis
8 Hong-hua Flos Carthami Warm 24.94% Unknown
9 Di-huang Radix Rehmanniae Cold 24.92% Pro-angiogenesis
10 Bai-shao Radix Paeoniae Alba Cool 21.89% Pro-angiogenesis
Table 3 Top 20 DMIM-extracted herb pairs
Rank Herb 1 Herb 2 DMIM
Score Chinese
Name
English Name Natural
Property
Chinese
Name
English Name Natural
Property
1 Mo-yao Myrrh Neutral Ru-xiang Frankincense Warm 2.9528
2 Hong-hua Flos Carthami Warm Tao-ren Semen Persicae Neutral 1.8057
3 E-zhu Rhizoma Curcumae Warm San-len Rhizoma Sparganii Neutral 0.97254
4 Long-gu Drgon’s Bones, Fossilizid Neutral Mu-li Concha Ostreae Cool 0.78572
5 Da-zao Fructus Jujubae Warm Shen-jiang Rhizoma Zingiberis Recens Warm 0.63477
6 Quan-xie Scorpio Neutral Wu-gong Scolopendra Warm 0.56607
7 Du-huo Radix Angelicae Pubescentis Warm Qiang-huo Rhizoma et Radix
Notopterygii
Warm 0.45846
8 Cang-zhu Rhizoma Atractylodis Warm Huang-bai Cortex Phellodendri Cold 0.43511
9 Pu-huang Pollen Typhae Neutral Wu-ling-zhi Trogopterus Dung Warm 0.42285
10 Bai-zhu Rhizoma Atractylodis
Macrocephalae
Warm Fu-ling Poria Neutral 0.41082
11 Shi-chang-pu Rhizoma Acori Tatarinowii Warm Yuan-zhi Radix Polygalae Warm 0.40238
12 Chi-shao Radix Paeoniae Rubra Cool Tao-ren Semen Persicae Neutral 0.39792
13* Jiang-can Bombyx Batryticatus Neutral Quan-xie Scorpio Neutral 0.3707
14 Ban-xia Rhizoma Pinelliae Warm Chen-pi Pericarpium Citri
Reticulatae
Warm 0.34629
15* Dang-shen Radix Codonopsis Neutral Huang-qi Radix Astragali Warm 0.34084
16* Chuan-xiong Rhizoma Chuanxiong Warm Hong-hua Flos Carthami Warm 0.32943
17* Chuan-xiong Rhizoma Chuanxiong Warm Tao-ren Semen Persicae Neutral 0.31513
18 Chuan-xiong Rhizoma Chuanxiong Warm Dang-gui Radix Angelicae Sinensis Warm 0.29861
19* Chi-shao Radix Paeoniae Rubra Cool Hong-hua Flos Carthami Warm 0.29351
20* Bai-zhu Rhizoma Atractylodis
Macrocephalae
Warm Dang-shen Radix Codonopsis Neutral 0.29154
195 Bai-shao Radix Paeoniae Alba Cool Gan-cao Radix Rhizoma Glycyrrhizae Neutral 0.052203
*: Herb pairs extracted by DMIM but not recorded in traditionally-defined herb pairs.
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2 test, P<0.05) (Figure 2A) and assumed that herbs
presented in this module could have potential angio-
genic activities. By selecting the major herbal ingredients
in these herbs and taking their natural properties into
consideration, the following in vitro experimental results
support our hypothesis. As shown in Figure 2B, in the
hub module, Vitexicarpin (VIT) and Timosaponin A-III
(TSA) as major ingredients taken from two herbs with
Cold properties were very active on inhibiting endothe-
lial cell proliferation (IC50VIT=3.2μM; IC50TSA=3.4μM
respectively). Also, Hydroxysafflor yellow A (HYA) and
Astragaloside (AST) from herbs with Hot properties had
partial pro-angiogenesis activities when compared with
the VEGF treatment group. Another trend (Figure 2B)
was that Berberine from Huang-bai (Cortex Phelloden-
dri) and Tetramethylpyrazine (TMP) from Chuan-xiong
had a biphasic effect on endothelial cells proliferation.
Lower doses caused an increase in cell proliferation
whereas higher doses resulted in an anti-angiogenic
response. Overall, the experimental results validated the
potential angiogenic activities of the modular herbs.
Measurement of DMIM-extracted modular herb
interactions
We evaluated whether modular herbs with different
properties had potential combination effects. Figure 3
s h o w st h a tH U V E C sw e r et r e a t e dw i t hd i f f e r e n tc o m -
pound combinations in a 6×6 dose matrix using the
same conditions as the cell growth assay. By using the
h i g h e s ts i n g l ec o m p o u n dm o d e l[ 1 8 ]w ef o u n dt h a t
TMP (from Chuan-xiong with Warm properties) in
combination with HYA (from Hong-hua with Warm
properties) caused moderate synergistic pro-angiogenic
activity, whereas antagonistic effects were observed
when TMP was combined with AST (from Huang-qi
with Warm properties). Noticeably, TMP and TSA
(from Zhi-mu with Cool properties) produced obvious
antagonism at higher concentrations (Figure 3). We also
Figure 1 DMIM-extracted herb network from 3865 herbal formula.This herb network is constructed from the top 100 herb pairs extracted
by DMIM. Herbs with different natural properties and six classical herbal formulae are presented in the network. Data about only two interacted
herbs are not shown.
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Page 6 of 12Figure 2 Angiogenic activities of major ingredients in DMIM-extracted herbs. A. The extended hub module in DMIM-extracted herb
network. Each node corresponds to a herb colored according to their natural properties. The size of each node is proportional to the number of
herbs connecting to it. A solid line links a herb pair while the width of the lines is proportional to the DMIM score. B. Experimental results of the
herb ingredients in the module. The pro- or anti-angiogenic effects of each herb were delineated by pro- or anti-angiogenic screening model
respectively.
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Page 7 of 12Figure 3 Combination effects in DMIM-extracted herb pairs.According to the HSC model, the dose matrix indicates the combined response
of TMP in combination with three other compounds at six different doses. The color of the gird denotes the level of cell growth stimulation or
inhibition. The growth percentage and inhibition percentage were calculated by the pro- or anti-angiogenic screening model respectively (A, C
and E). B, D and F show the calculated excess growth or inhibition percentage over the HSC additivity model. The percentage above or below
zero denotes the combination with synergism or antagonism, respectively.
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and Huang-qi, and the novel herb pairs Chuan-xiong
and Hong-hua identified by DMIM exhibited clear com-
bination effects on endothelial cell proliferation. These
results suggest that the different interaction patterns of
herb pairs may be associated with their different herb
properties, although this association remains unclear.
Co-module underlying DMIM-extracted herbal formula in
treating different diseases
DMIM can recover and connect all six herbs of the Liu-
wei-di-huang formula. This formula is reported to
potentially treat 16 types of diseases (Additional file 1).
Thus, we performed a co-module analysis to explore the
potential combination mechanism of DMIM-extracted
herbal formula. Table 4 shows that LWDH genes as
well as LWDH-disease genes are mainly enriched in
cancer pathways and neuro-endocrine-immune path-
ways (see Additional file 2 for detailed statistics).
Moreover, based on the PPI network, it is noted that
the average shortest path length is significantly smaller
between LWDH genes and LWDH-disease genes than
between LWDH genes and randomly selected disease
genes (P<0.0001, 2000 permutations). This highlights
the specificity of the LWDH for treating these 16 differ-
ent diseases. In addition to this, the average phenotype
similarity scores for these 16 LWDH diseases are higher
than the scores of random controls (P=0.0248, 2000
permutations), suggesting th a ti tm i g h tb ep o s s i b l et o
group together LWDH-treated diseases through a com-
mon molecular basis. These findings evidenced that
LWDH might act on a common network target underly-
ing these diseases, and we can capture the “one formula,
different diseases” relationship from a co-module view-
point based on multilayer networks of herb-biomole-
cule-disease (Figure 4).
Discussion
In this work, we proposed a distance-based mutual
information model, DMIM, to uncover the combination
rule embedded in herbal formulae, which not only uses
mutual information entropy but also introduces a new
factor, “between-herb-distance”, into measuring the ten-
d e n c yo ft w oh e r b st of o r ma nh e r bp a i r .T h i sm a k e s
DMIM suitable for deciphering herbal formulae and dis-
tinguishes it from other analytical methods such as clus-
tering. For example, herb1 and herb2 are often used
together to reduce toxicity and side-effects, while herb2
and herb3 m a yb ec l u s t e r e di n t oas i n g l ec a t e g o r y
because of their co-location in similar organs or meri-
dians. According to the principles of clustering, herb1,
herb2 and herb3 may be clustered into one category, but
in reality, herb1 and herb3 have no inherent relationship.
Moreover, the results of clustering are qualitative rather
than quantitative and clustering does not show which
herbs have a tendency to form herb pairs. DMIM avoids
Table 4 Enriched pathways of Liu-wei-di-huang genes and Liu-wei-di-huang-treated disease genes identified by DAVID
Category Enriched KEGG pathway False discovery rate
Liu-wei-di-huang genes hsa05200:Pathways in cancer 1.82E-06
hsa05014:Amyotrophic lateral sclerosis 3.82E-06
hsa04620:Toll-like receptor signaling pathway 6.42E-06
hsa04660:T cell receptor signaling pathway 1.56E-05
hsa04210:Apoptosis 8.13E-04
hsa04621:NOD-like receptor signaling pathway 0.002737
hsa05222:Small cell lung cancer 0.00471
hsa04080:Neuroactive ligand-receptor interaction 0.007635
hsa05210:Colorectal cancer 0.03486
Liu-wei-di-huang-treated hsa05200:Pathways in cancer 2.35E-12
disease genes hsa05210:Colorectal cancer 1.11E-07
hsa05221:Acute myeloid leukemia 2.58E-07
hsa05213:Endometrial cancer 5.92E-07
hsa05220:Chronic myeloid leukemia 9.79E-05
hsa05215:Prostate cancer 1.38E-04
hsa04930:Type II diabetes mellitus 2.25E-04
hsa05218:Melanoma 3.68E-04
hsa05216:Thyroid cancer 0.002937
hsa05214:Glioma 0.005064
hsa05223:Non-small cell lung cancer 0.008102
hsa04950:Maturity onset diabetes of the young 0.01155
hsa05212:Pancreatic cancer 0.019292
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entropy for each of the herbs and their “between-herb-
distance”.
We demonstrated the reliability and usefulness of
DMIM by using 3865 Collaterals-related herbal formulae.
Firstly, we showed that the DMIM method retains the
traditional combination rule of TCM. DMIM identified
many herbal pairs which have already been defined
(Table 3). We also found that the DMIM-extracted herb
network identified six classical herbal formulae from the
paired herbs (Figure 1), which are expressed as connected
sub-networks. On the other hand, DMIM-extracted herb
network can eliminate the disturbance from herbs such
as Gan-cao (Radix Rhizoma Glycyrrhizae), a widely used
“Guide” herb that coordinates the actions of other herbs
in formulae, though it ranks at top 2 in 3865 herbal
formulae.
Next, we showed that DMIM has the potential to dis-
cover angiogenic herbs and non-addictive herb pairs
from TCM. This study found that the 10 most common
herbs in the 3865 formulae had potential angiogenic
effects (Table 2) [9,22]. We also conducted in vitro
assay to evaluate the extended hub module for Chuan-
xiong (Rhizoma Chuanxiong)a n dD a n g - g u i( Radix
Angelicae Sinensis) in the DMIM-extracted herb net-
work (Figure 2A). As the ingredients of herbs are very
complicated and the quality of herbs is still unstable, for
simplify, this work used major ingredients of herbs to
perform experiments. Results showed that the herbs or
herb pairs in the hub modules produced anti-angiogenic
Figure 4 The co-module underlying Liu-wei-di-huang formula and diseases. For the herb module, two herbs from the Liu-wei-di-huang are
linked if they have common responsive genes. For the disease module, two diseases are linked if they have common disease genes. The width
of the solid lines is scaled with the number of common herb or disease genes. All herb genes and disease genes are mapped to the protein-
protein interaction network. A biomolecular module as a common network target and associated with both the herb module and the disease
module is extracted with dashed lines.
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herbs may have functional dependence. In particular, we
detected the novel bioactivity of two herb ingredients
which inhibited angiogenesis, including Vitexicarpin
(IC50 = 3.2 μM) and Timosaponin A-III (IC50 = 3.4 μM)
(Figure 2B). We also validated the synergistic effects pro-
duced by DMIM-extracted novel herb pairs such as
Chuan-xiong and Hong-hua (Table 3 and Figure 3).
Additionally, in this study, we observed that the active
compounds from the herbs with different natural prop-
erties might account for their different angiogenic
responses (Figure 2B). For instance, major ingredients
from Cool/Cold herbs tend to produce anti-angiogenic
activities whereas major ingredients from Warm/Hot
herbs tend to exert pro-angiogenic activities [22]. The
dose-response relationship is another way to understand
the characteristics of the herb’s natural properties. We
found that Berberine and Tetramethylpyrazine can
cause a pro-angiogenic effect at low dose and anti-
angiogenic effects at high dose (Figure 2B), suggesting
that some herbs may cause biphasic regulation if differ-
ent dosing regimens are used. For herb interaction
effects we assumed that herb pairs in a formula with the
same properties were more likely to lead to synergistic
interactions, whereas combinations with different prop-
erties were inclined to cause antagonism. As shown in
Figure 3, combination effects from herb pairs with the
same properties (e.g. Chuan-xiong and Hong-hua) and
different properties (e.g. Chuan-xiong and Zhi-mu) sup-
port our assumption, but the combination of Chuan-
xiong and Huang-qi is not the case, making it an open
question whether or not herbal properties are related to
herb combination behaviours.
Last but not least, we demonstrated that the DMIM-
extracted herbal formula, Liu-wei-di-huang, may have its
molecular basis for treating different diseases in a co-mod-
ule manner (Figure 4). LWDH is one of the most famous
TCM formulae developed during the Song dynasty in
China. Results show that the six herbs in LWDH not only
have high DMIM scores, but also connected closely with
common responsive genes enriched in cancer pathways
and neuro-endocrine-immune pathways (Table 4). Inter-
estingly, LWDH genes show a significantly close relation-
ship with LWDH-disease genes in the PPI network
(P<0.0001), forming a co-module underlying herbal for-
mula as well as different diseases. Moreover, the 16
LWDH-treated diseases mainly including cancer, neuro-
endocrine-immune-metabolism, and cardiovascular disor-
ders show high phenotype similarity scores (P=0.0248)
and might share a overlapped molecular basis associated
with the angiogenic processes as well as the imbalance of
the human body [23,24]. Such phenomena of “one for-
mula, different diseases” reinforce the idea that different
diseases with similar phenotypes might possess internal
coherence [25-27], and a group of diseases with similar
mechanisms might be able to be treated by intervening
their common network target [28,29], which in turn illus-
trates the rationality of multicomponent therapies such as
herbal formulae (Figure [4]). The novel concept of
co-module throughout the multilayer networks of herb-
biomolecule-diseases may promote our awareness of
herbal formulae as well as multicomponent therapies.
DMIM is currently the first step towards building herb
network from TCM herbal formula. For future work,
DMIM could be generalized to mine synergistic combi-
nations made up of more than two herbs by replacing
the “between-herb-distance” with a properly defined
index of the distance among multiple herbs in a formula
or by introducing multivariate mutual information. As
this work treats formula independently, we will take the
redundancies and correlations between formulae into
consideration for calculating the herb distance. The
dose information and natural properties of herbs (as
measures of interaction) are also the next step to create
a multi-weight herb network. Moreover, we believe that
the combination mechanism of herbal formulae will be
more deeply identified in a “co-module” manner and
contribute to the progression of the modern TCM as
well as network pharmacological studies [13].
Conclusions
DMIM yields a systematic framework for scoring herb
pairs and the resulted herb network can uncover some
combination rules of TCM. We also provide preliminary
clues that the “co-module” across multilayer networks of
herb-biomolecule-disease m a yb er e s p o n s i b l ef o rt h e
combination mechanism underlying herbal formulae.
This study is the first step forward in exploring the
unique theories of TCM herbal formula by network
biology approaches and may also benefit the coming
network pharmacology as well.
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